These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 21425212
1. Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis. Hanouneh IA, Macaron C, Lopez R, Zein NN, Lashner BA. Inflamm Bowel Dis; 2012 Feb; 18(2):269-74. PubMed ID: 21425212 [Abstract] [Full Text] [Related]
2. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF. Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898 [Abstract] [Full Text] [Related]
3. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis. Singh S, Edakkanambeth Varayil J, Loftus EV, Talwalkar JA. Liver Transpl; 2013 Dec 27; 19(12):1361-9. PubMed ID: 24019127 [Abstract] [Full Text] [Related]
5. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Mouchli MA, Singh S, Boardman L, Bruining DH, Lightner AL, Rosen CB, Heimbach JK, Hasan B, Poterucha JJ, Watt KD, Kane SV, Raffals LE, Loftus EV. Inflamm Bowel Dis; 2018 Apr 23; 24(5):1074-1081. PubMed ID: 29522202 [Abstract] [Full Text] [Related]
6. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report. Åberg F, Abdulle A, Mäkelä A, Nissinen M. Transplant Proc; 2015 Nov 23; 47(9):2775-7. PubMed ID: 26680092 [Abstract] [Full Text] [Related]
7. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study. Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW. Surgery; 2005 Oct 23; 138(4):631-7; discussion 637-9. PubMed ID: 16269291 [Abstract] [Full Text] [Related]
8. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series. Altwegg R, Combes R, Laharie D, De Ledinghen V, Radenne S, Conti F, Chazouilleres O, Duvoux C, Dumortier J, Leroy V, Treton X, Durand F, Dharancy S, Nachury M, Goutorbe F, Lamblin G, Boivineau L, Peyrin-Biroulet L, Pageaux GP. Dig Liver Dis; 2018 Jul 23; 50(7):668-674. PubMed ID: 29655972 [Abstract] [Full Text] [Related]
9. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes. Peverelle M, Paleri S, Hughes J, De Cruz P, Gow PJ. Inflamm Bowel Dis; 2020 Nov 19; 26(12):1901-1908. PubMed ID: 31944235 [Abstract] [Full Text] [Related]
13. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis. Hildebrand T, Pannicke N, Dechene A, Gotthardt DN, Kirchner G, Reiter FP, Sterneck M, Herzer K, Lenzen H, Rupp C, Barg-Hock H, de Leuw P, Teufel A, Zimmer V, Lammert F, Sarrazin C, Spengler U, Rust C, Manns MP, Strassburg CP, Schramm C, Weismüller TJ, German PSC Study Group. Liver Transpl; 2016 Jan 19; 22(1):42-52. PubMed ID: 26438008 [Abstract] [Full Text] [Related]
14. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients. Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM. Liver Transpl; 2016 Sep 19; 22(9):1214-22. PubMed ID: 27339253 [Abstract] [Full Text] [Related]
15. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease. Jørgensen KK, Lindström L, Cvancarova M, Karlsen TH, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM. Clin Gastroenterol Hepatol; 2013 May 19; 11(5):517-23. PubMed ID: 23333218 [Abstract] [Full Text] [Related]
16. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Shah SC, Ten Hove JR, Castaneda D, Palmela C, Mooiweer E, Colombel JF, Harpaz N, Ullman TA, van Bodegraven AA, Jansen JM, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Oldenburg B, Itzkowitz SH, Torres J. Clin Gastroenterol Hepatol; 2018 Jul 19; 16(7):1106-1113.e3. PubMed ID: 29378311 [Abstract] [Full Text] [Related]
18. The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation. Eaton JE, Smyrk TC, Imam M, Pardi DS, Loftus EV, Owens VL, Talwalkar JA. Aliment Pharmacol Ther; 2013 Oct 19; 38(8):977-87. PubMed ID: 24033551 [Abstract] [Full Text] [Related]